【港股股票回购一览：45只个股获公司回购】4月11日，共45只港股获公司回购，4只个股回购金额超千万港元。其中，药明生物、中国宏桥、太古股份公司A回购金额最大，分别获公司回购1.98亿港元、6791.51万港元、1948.77万港元。截至4月11日，今年已有170只港股获公司回购，25只个股年内累计回购金额超亿港元。其中，腾讯控股、汇丰控股、友邦保险年内累计回购金额最大，分别获公司回购210.26亿港元、108.45亿港元、52.57亿港元。

金融界2025-04-14

4月11日，共45只港股获公司回购，4只个股回购金额超千万港元。其中，药明生物、中国宏桥、太古股份公司A回购金额最大，分别获公司回购1.98亿港元、6791.51万港元、1948.77万港元。截至4月11日，今年已有170只港股获公司回购，25只个股年内累计回购金额超亿港元。其中，腾讯控股、汇丰控股、友邦保险年内累计回购金额最大，分别获公司回购210.26亿港元、108.45亿港元、52.57...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2527910906?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-14 09:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2527910906","market":"sh","top_or_hot":-1,"title":"【港股股票回购一览：45只个股获公司回购】4月11日，共45只港股获公司回购，4只个股回购金额超千万港元。其中，药明生物、中国宏桥、太古股份公司A回购金额最大，分别获公司回购1.98亿港元、6791.51万港元、1948.77万港元。截至4月11日，今年已有170只港股获公司回购，25只个股年内累计回购金额超亿港元。其中，腾讯控股、汇丰控股、友邦保险年内累计回购金额最大，分别获公司回购210.26亿港元、108.45亿港元、52.57亿港元。","media":"金融界","content":"<div>\n<p>4月11日，共45只港股获公司回购，4只个股回购金额超千万港元。其中，药明生物、中国宏桥、太古股份公司A回购金额最大，分别获公司回购1.98亿港元、6791.51万港元、1948.77万港元。截至4月11日，今年已有170只港股获公司回购，25只个股年内累计回购金额超亿港元。其中，腾讯控股、汇丰控股、友邦保险年内累计回购金额最大，分别获公司回购210.26亿港元、108.45亿港元、52.57...</p>\n\n<a href=\"https://24h.jrj.com.cn/2025/04/14090549513344.shtml\">网页链接</a>\n\n</div>\n","source":"jinrongjie_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>【港股股票回购一览：45只个股获公司回购】4月11日，共45只港股获公司回购，4只个股回购金额超千万港元。其中，药明生物、中国宏桥、太古股份公司A回购金额最大，分别获公司回购1.98亿港元、6791.51万港元、1948.77万港元。截至4月11日，今年已有170只港股获公司回购，25只个股年内累计回购金额超亿港元。其中，腾讯控股、汇丰控股、友邦保险年内累计回购金额最大，分别获公司回购210.26亿港元、108.45亿港元、52.57亿港元。</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n【港股股票回购一览：45只个股获公司回购】4月11日，共45只港股获公司回购，4只个股回购金额超千万港元。其中，药明生物、中国宏桥、太古股份公司A回购金额最大，分别获公司回购1.98亿港元、6791.51万港元、1948.77万港元。截至4月11日，今年已有170只港股获公司回购，25只个股年内累计回购金额超亿港元。其中，腾讯控股、汇丰控股、友邦保险年内累计回购金额最大，分别获公司回购210.26亿港元、108.45亿港元、52.57亿港元。\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-14 09:05 北京时间&nbsp;&nbsp;&nbsp;<a href=https://24h.jrj.com.cn/2025/04/14090549513344.shtml><strong>金融界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>4月11日，共45只港股获公司回购，4只个股回购金额超千万港元。其中，药明生物、中国宏桥、太古股份公司A回购金额最大，分别获公司回购1.98亿港元、6791.51万港元、1948.77万港元。截至4月11日，今年已有170只港股获公司回购，25只个股年内累计回购金额超亿港元。其中，腾讯控股、汇丰控股、友邦保险年内累计回购金额最大，分别获公司回购210.26亿港元、108.45亿港元、52.57...</p>\n\n<a href=\"https://24h.jrj.com.cn/2025/04/14090549513344.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0516422440.USD","symbol_name":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"A\" (USD) ACC","start_time":0,"source_url":"https://24h.jrj.com.cn/2025/04/14090549513344.shtml","article_id":"2527910906","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2527910906","pubTimestamp":1744592749,"columns":[],"sourceInfo":{"source_id":"jinrongjie_stock","name":"金融界"},"weMediaInfo":null,"summary":"4月11日，共45只港股获公司回购，4只个股回购金额超千万港元。其中，药明生物、中国宏桥、太古股份公司A回购金额最大，分别获公司回购1.98亿港元、6791.51万港元、1948.77万港元。截至4月11日，今年已有170只港股获公司回购，25只个股年内累计回购金额超亿港元。其中，腾讯控股、汇丰控股、友邦保险年内累计回购金额最大，分别获公司回购210.26亿港元、108.45亿港元、52.57亿港元。","collect":0,"end_time":0,"defaultTopTitle":"jrj.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"80700":"腾讯控股-R","81299":"友邦保险-R","LU0516422440.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"A\" (USD) ACC","LU0572940350.SGD":"Janus Henderson Horizon Asian Dividend Income A3 SGD","LU1993786604.SGD":"UBS (LUX) EQUITY SICAV ALL CHINA \"P\" (SGD) ACC","HSBC":"汇丰","SG9999001846.SGD":"Schroder Asian Equity Yield A Dis SGD","01299":"友邦保险","BK1615":"港股-互联网","SG9999010078.USD":"UNITED ASIA PACIFIC REAL ESTATE INCOME (USDHDG) INC","LU0608807433.USD":"TEMPLETON EMERGING MARKETS DYNAMIC INCOME \"A\" (USD) ACC","LU0029874905.USD":"TEMPLETON EMERGING MARKETS \"A\" INC","BK1592":"有色金属","IE00BPRC5H50.USD":"NEUBERGER BERMAN CHINA EQUITY \"A\" (USD) INC","IE00B067MR52.USD":"FSSA ASIAN EQUITY PLUS \"I\" (USD) ACC","01378":"中国宏桥","LU0164880469.USD":"HSBC GIF HONG KONG EQUITY \"AC\" ACC","LU1868838027.USD":"CT (LUX) I GLOBAL EMERGING MARKET EQUITIES \"8\" (USD) ACC","LU0106259558.USD":"SCHRODER ISF ASIAN OPPORTUNITIES \"A\" ACC","LU0633140560.USD":"AB EMERGING MARKET MULTI ASSET PORTFOLIO \"A\" (USD) ACC","LU0955669360.SGD":"Schroder ISF Asian Dividend Maximiser A Dis SGD","LU0786609619.USD":"高盛全球千禧一代股票组合Acc","IE0003895053.USD":"PINEBRIDGE ASIA DYNAMIC ASSET ALLOCATION \"AD\" USD  ACC","LU2362541273.HKD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (HKD) ACC","LU0878005551.USD":"UBS (LUX) KEY SELEC ASIA ALLOCATION OPPORTUNITY (USD) \"P\" (USD) ACC","LU1328615791.USD":"FULLERTON LUX FUNDS - ALL CHINA EQUITIES \"I\" (USD) ACC","HSTECH":"恒生科技指数","LU0862451753.SGD":"JPMorgan Funds - Emerging Markets Dividend A (mth) SGD","LU2153592121.USD":"Aberdeen Standard SICAV I - Emerging Markets Sustainable Development Equity A Acc USD","YANG":"三倍做空富时中国ETF-Direxion","LU0214875030.USD":"HSBC GIF BRIC EQUITY \"M2C\" (USD) ACC","LU0456827905.SGD":"JPMorgan Funds - China A (acc) SGD","LU1226288170.HKD":"UBS (LUX) KEY SEL S-CHINA ALLOCATION OPP \"P6%\"(HK D) INC","HTCD.SI":"Tencent HK SDR 10to1","SGXZ23171101.USD":"NIKKO AM SHENTON GLOBAL OPPORTUNITIES (USD) ACC","BK4585":"ETF&股票定投概念","02269":"药明生物","LU1235295612.USD":"FIDELITY PACIFIC \"A\" (USDHDG) INC","LU0831093199.SGD":"HSBC GIF MANAGED SOLUTIONS ASIA FOCUSED INCOME \"AM3\" (SGDHDG) INC","00019":"太古股份公司A","IE00BKZH1Z71.USD":"BNY MELLON ASIAN INCOME \"B\" (USD) ACC","AAGIY":"友邦保险ADR","LU2087589342.USD":"BGF ASIAN MULTI-ASSET INCOME \"A6\" (USD) INC","HK0000320223.HKD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (HKD) ACC","SG9999014906.USD":"大华全球优质成长基金Acc USD","LU2097828714.EUR":"AZ EQUITY CHINA \"BAZ\" (EUR) ACC"},"translate_title":"[List of Hong Kong stock repurchases: 45 stocks were repurchased by the company] On April 11, a total of 45 Hong Kong stocks were repurchased by the company, and the repurchase amount of 4 stocks exceeded HK $10 million. Among them, WuXi Biologics, China Hongqiao, and Swire Pacific A have the largest repurchase amounts, with the company's repurchase of HK $198 million, HK $67.9151 million, and HK $19.4877 million respectively. As of April 11, 170 Hong Kong stocks have been repurchased by the company this year, and the cumulative repurchase amount of 25 stocks during the year exceeded HK $100 m","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"80700":0.6,"81299":0.6,"HTCD.SI":0.6,"01299":1,"HSBC":1,"02269":1,"00019":1,"01378":1,"AAGIY":0.6,"HSTECH":1,"YANG":1},"content_text":"4月11日，共45只港股获公司回购，4只个股回购金额超千万港元。其中，药明生物、中国宏桥、太古股份公司A回购金额最大，分别获公司回购1.98亿港元、6791.51万港元、1948.77万港元。截至4月11日，今年已有170只港股获公司回购，25只个股年内累计回购金额超亿港元。其中，腾讯控股、汇丰控股、友邦保险年内累计回购金额最大，分别获公司回购210.26亿港元、108.45亿港元、52.57亿港元。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,buyback","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2527910906","isCrawlerRequest":true}